ArticleBMC gastroenterology2026
Diagnostic delay in children with coeliac disease: a national multicentre study in Turkey.
Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Gluten-Free Diet Adherence and BMI z-Scores in Pediatric Celiac Disease: Distinguishing Recovery From Excess Weight Gain.Pediatrics international : official journal of the Japan Pediatric SocietyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThere are few studies conducted investigating diagnostic delay in children with coeliac disease (CD). A better understanding of the factors associated with diagnostic delay and the development of strategies to reduce it are important in preventing long-term complications related to the disease. This study aimed to determine the median diagnostic delay in children with CD and to investigate possible underlying factors associated with diagnostic delay.
methodsA prospective screening program was performed in children with CD at the seven clinical centers operating in Turkey within the Focus IN CD project between June 2021 and June 2023. Paediatric gastroenterologists were asked to complete a web-based questionnaire about CD.
resultsThe median age of the 188 children with CD (66 male; 35%) was 8.33 years (IQR: 5.02-13.00). The median diagnostic delay was 7.30 months (IQR: 2.73–15.50). Among the 188 patients included in the study, 172 (91.5%) were diagnosed within the first three years, whereas 16 (8.5%) were diagnosed after three years, and 68.7% of these patients had classical CD symptoms. Patients with CD were categorised according to the OSLO criteria. The median delay for the classic CD group, the nonclassic CD group and the silent CD group were found to be 7.63 (IQR: 3.13–16.06), 4.40 (IQR: 1.76–13.20) and 2.21 (IQR: 1.03–16.14) months, respectively. There were no significant differences between the patients with the classic CD group, and the nonclassic CD group, and the silent CD group (p = 0.564).
conclusionsThe study revealed that the median diagnostic delay was 7.30 months. Furthermore there were no significant differences between clinical subtypes of CD. In order to minimize the delay in diagnosis, it may be a solution to raise community-based awareness of CD, and better inform pediatricians, and family physicians about CD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.